scholarly article | Q13442814 |
P50 | author | John Kopchick | Q6243403 |
P2093 | author name string | Juan Ding | |
Darlene E Berryman | |||
P2860 | cites work | Effect of growth hormone on susceptibility to diet-induced obesity | Q82927691 |
Acromegaly | Q21202912 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 | Q28216275 | ||
Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries | Q28566878 | ||
Regulation of rat thyroxine-binding globulin and transthyretin: studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/and growth hormone | Q28568839 | ||
Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding | Q28579041 | ||
alpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis. | Q31008087 | ||
Mining biomarkers in human sera using proteomic tools | Q33196952 | ||
Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 | ||
Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: a cross-sectional analysis | Q33564769 | ||
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control | Q33576525 | ||
Biological effects of growth hormone on carbohydrate and lipid metabolism. | Q33625416 | ||
Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity. | Q33817041 | ||
Increased mortality associated with growth hormone treatment in critically ill adults | Q33873359 | ||
Mannose binding lectin genotypes influence recovery from hepatitis B virus infection | Q33883928 | ||
Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice | Q33973509 | ||
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways | Q34575948 | ||
The role of apolipoprotein E in Alzheimer's disease | Q34603092 | ||
Production of pharmaceutical proteins by transgenic animals | Q34744705 | ||
Growth hormone and mannan-binding lectin: emerging evidence for hormonal regulation of humoral innate immunity | Q35079573 | ||
Plasma biomarkers of mouse aging | Q35201170 | ||
The role of mannose-binding lectin in health and disease | Q35563974 | ||
alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis | Q35787857 | ||
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. | Q35811511 | ||
Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions | Q35833554 | ||
Hepatic proteins and nutrition assessment | Q35849247 | ||
Fasting hyperglycemia: etiology, diagnosis, and treatment | Q35867553 | ||
Foundation Review: Transgenic animals and their impact on the drug discovery industry. | Q36143388 | ||
The pitfalls of proteomics experiments without the correct use of bioinformatics tools. | Q36601078 | ||
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B | Q36672274 | ||
Age-related changes in body composition of bovine growth hormone transgenic mice | Q37125980 | ||
Novel serum biomarkers for erythropoietin use in humans: a proteomic approach. | Q37202283 | ||
Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system | Q37368642 | ||
Guidelines for acromegaly management: an update | Q37390174 | ||
Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases | Q37763476 | ||
Prolactin induction of the alpha 2-Macroglobulin gene in rat ovarian granulosa cells: stat 5 activation and binding to the interleukin-6 response element | Q38362059 | ||
Raised Alpha-2-Macroglobulin Levels in Acromegaly | Q39501210 | ||
Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer | Q40376842 | ||
Molecular Analysis of the Human and Mouse α2M Family | Q40393738 | ||
Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro. | Q40885571 | ||
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. | Q41781799 | ||
Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin | Q42442408 | ||
Aberrations in carbohydrate metabolism in patients with diagnosed acromegaly, hospitalized in the Endocrinology and Diabetology Department of Collegium Medicum University of Nicolaus Copernicus in Bydgoszcz in the years 2001-2009. | Q42985966 | ||
Acute effects of growth hormone on metabolism of pancreatic hormones, glucose and ketone bodies | Q43621371 | ||
Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice | Q43690324 | ||
Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms | Q43743280 | ||
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice | Q43794376 | ||
GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. | Q43794573 | ||
Humoral immune response in mice over-expressing or deficient in growth hormone. | Q44047699 | ||
Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors | Q44055137 | ||
Genetically enhanced cows resist intramammary Staphylococcus aureus infection | Q44213530 | ||
Age-related inflammatory cytokines and disease | Q44662101 | ||
The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome | Q44794011 | ||
Growth hormone regulation of serum lipoproteins in the rat: different growth hormone regulatory principles for apolipoprotein (apo) B and the sexually dimorphic apo E concentrations | Q44937288 | ||
Effects of Soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice | Q45028361 | ||
Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction | Q45119352 | ||
Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. | Q45147939 | ||
Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. | Q45996949 | ||
Small vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly | Q46143598 | ||
The influence of age on the GH-IGF1 axis in patients with acromegaly | Q46463817 | ||
Differentially expressed proteins in the pancreas of diet-induced diabetic mice | Q46551319 | ||
Comparing adiposity profiles in three mouse models with altered GH signaling | Q47256072 | ||
Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones | Q47354503 | ||
Age-dependent increase of clusterin in the human pituitary gland | Q47858080 | ||
Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays | Q48010555 | ||
Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. | Q48085244 | ||
Premature ageing in transgenic mice expressing different growth hormone genes | Q48386543 | ||
Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I. | Q50912310 | ||
The cardiovascular phenotype of a mouse model of acromegaly. | Q52592324 | ||
Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer. | Q53445502 | ||
Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. | Q53566667 | ||
Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. | Q54079237 | ||
Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models | Q57198146 | ||
Increased Overnight Growth Hormone Concentrations in Diabetic Compared with Normal Adolescents | Q58811293 | ||
Transthyretin (prealbumin) in the pancreas and sera of newly diagnosed type I (insulin-dependent) diabetic patients | Q68135520 | ||
Molecular basis of opsonic defect in immunodeficient children | Q68303831 | ||
Expression of Insulin-Like Growth Factor I in Transgenic Mice with Elevated Levels of Growth Hormone Is Correlated with Growth* | Q68411075 | ||
Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice | Q69834305 | ||
Use of gene transfer to increase animal growth | Q70133022 | ||
Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes | Q71563371 | ||
Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo | Q71583678 | ||
Induction of an acute phase response in lambs causes an increase in plasma levels of GH and IGF-I | Q72133772 | ||
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
Proteinase inhibitor activity of blood plasma and cerebrospinal fluid in patients with pituitary adenomas before and after proton therapy | Q72726615 | ||
Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes | Q72753202 | ||
Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene | Q72829677 | ||
Transformed alpha 2-macroglobulin as a low-affinity growth hormone-binding protein | Q73122585 | ||
Growth hormone stimulates the proliferation of activated mouse T lymphocytes | Q73251501 | ||
Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene | Q73832200 | ||
Monocyte cytokine production in an elderly population: effect of age and inflammation | Q74188620 | ||
Leptin expression in porcine adipose tissue is not increased by endotoxin but is reduced by growth hormone | Q77759006 | ||
Protein status in pancreatitis--transthyretin is a sensitive biomarker of malnutrition in acute and chronic pancreatitis | Q78848929 | ||
Effects of mild calorie restriction on reproduction, plasma parameters and hepatic gene expression in mice with altered GH/IGF-I axis | Q80004195 | ||
Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetes | Q80052155 | ||
The origins of age-related proinflammatory state | Q81079607 | ||
Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension | Q81192434 | ||
Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone | Q82038059 | ||
P433 | issue | 6 | |
P304 | page(s) | 1305-1320 | |
P577 | publication date | 2011-03-02 | |
P1433 | published in | Transgenic Research | Q7834239 |
P1476 | title | Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. | |
P478 | volume | 20 |
Q36112487 | Age- and sex-associated plasma proteomic changes in growth hormone receptor gene-disrupted mice |
Q36253119 | Decreased insulin sensitivity and increased oxidative damage in wasting adipose tissue depots of wild-type mice |
Q35223038 | Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome |
Q37594091 | Elevated systolic blood pressure in male GH transgenic mice is age dependent. |
Q36626322 | Growth Hormone Influence on the Morphology and Size of the Mouse Meibomian Gland. |
Q50938379 | Insights into the function of n-3 PUFAs in fat-1 transgenic cattle. |
Q47939996 | Insulin, IGF-1, and GH Receptors Are Altered in an Adipose Tissue Depot-Specific Manner in Male Mice With Modified GH Action. |
Q35436137 | Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations. |
Q37130681 | Mouse models of growth hormone action and aging: a proteomic perspective |
Q38097351 | The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations |
Q33857579 | The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies. |
Search more.